0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vascular Embolization Agent Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-2D13682
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Vascular Embolization Agent Market Insights Forecast to 2029
BUY CHAPTERS

Global Vascular Embolization Agent Market Research Report 2024

Code: QYRE-Auto-2D13682
Report
October 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vascular Embolization Agent Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Vascular Embolization Agent Market

Vascular Embolization Agent Market

The global Vascular Embolization Agent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Vascular Embolization Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vascular Embolization Agent.

Report Scope

The Vascular Embolization Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vascular Embolization Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vascular Embolization Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Vascular Embolization Agent Market Report

Report Metric Details
Report Name Vascular Embolization Agent Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Temporary
  • Permanent
Segment by Application
  • Hospital
  • Ambulatory Surgery Center
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, SSEM Mthembu Medical (Pty) Ltd, Balt USA LLC, Stryker, Guerbet LLC, Terumo Corporation, Penumbra, Grandpharma (Sirtex), Merit Medical, Siemens Healthineers (Varian), Jiangsu Hengrui Medicine, Kaneka, Meril Life Sciences, Peijia Medical, Wallaby Medical, MicroPort Scientific Corporation, Weihai Visee Medical Devices, Beijing Taijieweiye Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vascular Embolization Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vascular Embolization Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Vascular Embolization Agent Market report?

Ans: The main players in the Vascular Embolization Agent Market are Abbott, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, SSEM Mthembu Medical (Pty) Ltd, Balt USA LLC, Stryker, Guerbet LLC, Terumo Corporation, Penumbra, Grandpharma (Sirtex), Merit Medical, Siemens Healthineers (Varian), Jiangsu Hengrui Medicine, Kaneka, Meril Life Sciences, Peijia Medical, Wallaby Medical, MicroPort Scientific Corporation, Weihai Visee Medical Devices, Beijing Taijieweiye Technology

What are the Application segmentation covered in the Vascular Embolization Agent Market report?

Ans: The Applications covered in the Vascular Embolization Agent Market report are Hospital, Ambulatory Surgery Center

What are the Type segmentation covered in the Vascular Embolization Agent Market report?

Ans: The Types covered in the Vascular Embolization Agent Market report are Temporary, Permanent

1 Vascular Embolization Agent Market Overview
1.1 Product Overview and Scope of Vascular Embolization Agent
1.2 Vascular Embolization Agent Segment by Type
1.2.1 Global Vascular Embolization Agent Market Value Comparison by Type (2024-2030)
1.2.2 Temporary
1.2.3 Permanent
1.3 Vascular Embolization Agent Segment by Application
1.3.1 Global Vascular Embolization Agent Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.4 Global Vascular Embolization Agent Market Size Estimates and Forecasts
1.4.1 Global Vascular Embolization Agent Revenue 2019-2030
1.4.2 Global Vascular Embolization Agent Sales 2019-2030
1.4.3 Global Vascular Embolization Agent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vascular Embolization Agent Market Competition by Manufacturers
2.1 Global Vascular Embolization Agent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vascular Embolization Agent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vascular Embolization Agent Average Price by Manufacturers (2019-2024)
2.4 Global Vascular Embolization Agent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vascular Embolization Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vascular Embolization Agent, Product Type & Application
2.7 Vascular Embolization Agent Market Competitive Situation and Trends
2.7.1 Vascular Embolization Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vascular Embolization Agent Players Market Share by Revenue
2.7.3 Global Vascular Embolization Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vascular Embolization Agent Retrospective Market Scenario by Region
3.1 Global Vascular Embolization Agent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vascular Embolization Agent Global Vascular Embolization Agent Sales by Region: 2019-2030
3.2.1 Global Vascular Embolization Agent Sales by Region: 2019-2024
3.2.2 Global Vascular Embolization Agent Sales by Region: 2025-2030
3.3 Global Vascular Embolization Agent Global Vascular Embolization Agent Revenue by Region: 2019-2030
3.3.1 Global Vascular Embolization Agent Revenue by Region: 2019-2024
3.3.2 Global Vascular Embolization Agent Revenue by Region: 2025-2030
3.4 North America Vascular Embolization Agent Market Facts & Figures by Country
3.4.1 North America Vascular Embolization Agent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vascular Embolization Agent Sales by Country (2019-2030)
3.4.3 North America Vascular Embolization Agent Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vascular Embolization Agent Market Facts & Figures by Country
3.5.1 Europe Vascular Embolization Agent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vascular Embolization Agent Sales by Country (2019-2030)
3.5.3 Europe Vascular Embolization Agent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vascular Embolization Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Vascular Embolization Agent Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vascular Embolization Agent Sales by Country (2019-2030)
3.6.3 Asia Pacific Vascular Embolization Agent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vascular Embolization Agent Market Facts & Figures by Country
3.7.1 Latin America Vascular Embolization Agent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vascular Embolization Agent Sales by Country (2019-2030)
3.7.3 Latin America Vascular Embolization Agent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vascular Embolization Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Vascular Embolization Agent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vascular Embolization Agent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vascular Embolization Agent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vascular Embolization Agent Sales by Type (2019-2030)
4.1.1 Global Vascular Embolization Agent Sales by Type (2019-2024)
4.1.2 Global Vascular Embolization Agent Sales by Type (2025-2030)
4.1.3 Global Vascular Embolization Agent Sales Market Share by Type (2019-2030)
4.2 Global Vascular Embolization Agent Revenue by Type (2019-2030)
4.2.1 Global Vascular Embolization Agent Revenue by Type (2019-2024)
4.2.2 Global Vascular Embolization Agent Revenue by Type (2025-2030)
4.2.3 Global Vascular Embolization Agent Revenue Market Share by Type (2019-2030)
4.3 Global Vascular Embolization Agent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vascular Embolization Agent Sales by Application (2019-2030)
5.1.1 Global Vascular Embolization Agent Sales by Application (2019-2024)
5.1.2 Global Vascular Embolization Agent Sales by Application (2025-2030)
5.1.3 Global Vascular Embolization Agent Sales Market Share by Application (2019-2030)
5.2 Global Vascular Embolization Agent Revenue by Application (2019-2030)
5.2.1 Global Vascular Embolization Agent Revenue by Application (2019-2024)
5.2.2 Global Vascular Embolization Agent Revenue by Application (2025-2030)
5.2.3 Global Vascular Embolization Agent Revenue Market Share by Application (2019-2030)
5.3 Global Vascular Embolization Agent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Vascular Embolization Agent Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Corporation Vascular Embolization Agent Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Cook Medical LLC
6.3.1 Cook Medical LLC Corporation Information
6.3.2 Cook Medical LLC Description and Business Overview
6.3.3 Cook Medical LLC Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cook Medical LLC Vascular Embolization Agent Product Portfolio
6.3.5 Cook Medical LLC Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Vascular Embolization Agent Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Corporation Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medtronic Vascular Embolization Agent Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 Acandis GmbH
6.6.1 Acandis GmbH Corporation Information
6.6.2 Acandis GmbH Description and Business Overview
6.6.3 Acandis GmbH Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Acandis GmbH Vascular Embolization Agent Product Portfolio
6.6.5 Acandis GmbH Recent Developments/Updates
6.7 SSEM Mthembu Medical (Pty) Ltd
6.6.1 SSEM Mthembu Medical (Pty) Ltd Corporation Information
6.6.2 SSEM Mthembu Medical (Pty) Ltd Description and Business Overview
6.6.3 SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Product Portfolio
6.7.5 SSEM Mthembu Medical (Pty) Ltd Recent Developments/Updates
6.8 Balt USA LLC
6.8.1 Balt USA LLC Corporation Information
6.8.2 Balt USA LLC Description and Business Overview
6.8.3 Balt USA LLC Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Balt USA LLC Vascular Embolization Agent Product Portfolio
6.8.5 Balt USA LLC Recent Developments/Updates
6.9 Stryker
6.9.1 Stryker Corporation Information
6.9.2 Stryker Description and Business Overview
6.9.3 Stryker Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Stryker Vascular Embolization Agent Product Portfolio
6.9.5 Stryker Recent Developments/Updates
6.10 Guerbet LLC
6.10.1 Guerbet LLC Corporation Information
6.10.2 Guerbet LLC Description and Business Overview
6.10.3 Guerbet LLC Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Guerbet LLC Vascular Embolization Agent Product Portfolio
6.10.5 Guerbet LLC Recent Developments/Updates
6.11 Terumo Corporation
6.11.1 Terumo Corporation Corporation Information
6.11.2 Terumo Corporation Vascular Embolization Agent Description and Business Overview
6.11.3 Terumo Corporation Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Terumo Corporation Vascular Embolization Agent Product Portfolio
6.11.5 Terumo Corporation Recent Developments/Updates
6.12 Penumbra
6.12.1 Penumbra Corporation Information
6.12.2 Penumbra Vascular Embolization Agent Description and Business Overview
6.12.3 Penumbra Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Penumbra Vascular Embolization Agent Product Portfolio
6.12.5 Penumbra Recent Developments/Updates
6.13 Grandpharma (Sirtex)
6.13.1 Grandpharma (Sirtex) Corporation Information
6.13.2 Grandpharma (Sirtex) Vascular Embolization Agent Description and Business Overview
6.13.3 Grandpharma (Sirtex) Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Grandpharma (Sirtex) Vascular Embolization Agent Product Portfolio
6.13.5 Grandpharma (Sirtex) Recent Developments/Updates
6.14 Merit Medical
6.14.1 Merit Medical Corporation Information
6.14.2 Merit Medical Vascular Embolization Agent Description and Business Overview
6.14.3 Merit Medical Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Merit Medical Vascular Embolization Agent Product Portfolio
6.14.5 Merit Medical Recent Developments/Updates
6.15 Siemens Healthineers (Varian)
6.15.1 Siemens Healthineers (Varian) Corporation Information
6.15.2 Siemens Healthineers (Varian) Vascular Embolization Agent Description and Business Overview
6.15.3 Siemens Healthineers (Varian) Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Siemens Healthineers (Varian) Vascular Embolization Agent Product Portfolio
6.15.5 Siemens Healthineers (Varian) Recent Developments/Updates
6.16 Jiangsu Hengrui Medicine
6.16.1 Jiangsu Hengrui Medicine Corporation Information
6.16.2 Jiangsu Hengrui Medicine Vascular Embolization Agent Description and Business Overview
6.16.3 Jiangsu Hengrui Medicine Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Jiangsu Hengrui Medicine Vascular Embolization Agent Product Portfolio
6.16.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.17 Kaneka
6.17.1 Kaneka Corporation Information
6.17.2 Kaneka Vascular Embolization Agent Description and Business Overview
6.17.3 Kaneka Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Kaneka Vascular Embolization Agent Product Portfolio
6.17.5 Kaneka Recent Developments/Updates
6.18 Meril Life Sciences
6.18.1 Meril Life Sciences Corporation Information
6.18.2 Meril Life Sciences Vascular Embolization Agent Description and Business Overview
6.18.3 Meril Life Sciences Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Meril Life Sciences Vascular Embolization Agent Product Portfolio
6.18.5 Meril Life Sciences Recent Developments/Updates
6.19 Peijia Medical
6.19.1 Peijia Medical Corporation Information
6.19.2 Peijia Medical Vascular Embolization Agent Description and Business Overview
6.19.3 Peijia Medical Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Peijia Medical Vascular Embolization Agent Product Portfolio
6.19.5 Peijia Medical Recent Developments/Updates
6.20 Wallaby Medical
6.20.1 Wallaby Medical Corporation Information
6.20.2 Wallaby Medical Vascular Embolization Agent Description and Business Overview
6.20.3 Wallaby Medical Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Wallaby Medical Vascular Embolization Agent Product Portfolio
6.20.5 Wallaby Medical Recent Developments/Updates
6.21 MicroPort Scientific Corporation
6.21.1 MicroPort Scientific Corporation Corporation Information
6.21.2 MicroPort Scientific Corporation Vascular Embolization Agent Description and Business Overview
6.21.3 MicroPort Scientific Corporation Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.21.4 MicroPort Scientific Corporation Vascular Embolization Agent Product Portfolio
6.21.5 MicroPort Scientific Corporation Recent Developments/Updates
6.22 Weihai Visee Medical Devices
6.22.1 Weihai Visee Medical Devices Corporation Information
6.22.2 Weihai Visee Medical Devices Vascular Embolization Agent Description and Business Overview
6.22.3 Weihai Visee Medical Devices Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Weihai Visee Medical Devices Vascular Embolization Agent Product Portfolio
6.22.5 Weihai Visee Medical Devices Recent Developments/Updates
6.23 Beijing Taijieweiye Technology
6.23.1 Beijing Taijieweiye Technology Corporation Information
6.23.2 Beijing Taijieweiye Technology Vascular Embolization Agent Description and Business Overview
6.23.3 Beijing Taijieweiye Technology Vascular Embolization Agent Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Beijing Taijieweiye Technology Vascular Embolization Agent Product Portfolio
6.23.5 Beijing Taijieweiye Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vascular Embolization Agent Industry Chain Analysis
7.2 Vascular Embolization Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vascular Embolization Agent Production Mode & Process
7.4 Vascular Embolization Agent Sales and Marketing
7.4.1 Vascular Embolization Agent Sales Channels
7.4.2 Vascular Embolization Agent Distributors
7.5 Vascular Embolization Agent Customers
8 Vascular Embolization Agent Market Dynamics
8.1 Vascular Embolization Agent Industry Trends
8.2 Vascular Embolization Agent Market Drivers
8.3 Vascular Embolization Agent Market Challenges
8.4 Vascular Embolization Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Vascular Embolization Agent Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Vascular Embolization Agent Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Vascular Embolization Agent Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Vascular Embolization Agent Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Vascular Embolization Agent Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Vascular Embolization Agent Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Vascular Embolization Agent Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Vascular Embolization Agent Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Vascular Embolization Agent, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Vascular Embolization Agent, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Vascular Embolization Agent, Product Type & Application
    Table 12. Global Key Manufacturers of Vascular Embolization Agent, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Vascular Embolization Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Embolization Agent as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Vascular Embolization Agent Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Vascular Embolization Agent Sales by Region (2019-2024) & (K Units)
    Table 18. Global Vascular Embolization Agent Sales Market Share by Region (2019-2024)
    Table 19. Global Vascular Embolization Agent Sales by Region (2025-2030) & (K Units)
    Table 20. Global Vascular Embolization Agent Sales Market Share by Region (2025-2030)
    Table 21. Global Vascular Embolization Agent Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Vascular Embolization Agent Revenue Market Share by Region (2019-2024)
    Table 23. Global Vascular Embolization Agent Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Vascular Embolization Agent Revenue Market Share by Region (2025-2030)
    Table 25. North America Vascular Embolization Agent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Vascular Embolization Agent Sales by Country (2019-2024) & (K Units)
    Table 27. North America Vascular Embolization Agent Sales by Country (2025-2030) & (K Units)
    Table 28. North America Vascular Embolization Agent Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Vascular Embolization Agent Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Vascular Embolization Agent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Vascular Embolization Agent Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Vascular Embolization Agent Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Vascular Embolization Agent Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Vascular Embolization Agent Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Vascular Embolization Agent Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Vascular Embolization Agent Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Vascular Embolization Agent Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Vascular Embolization Agent Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Vascular Embolization Agent Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Vascular Embolization Agent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Vascular Embolization Agent Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Vascular Embolization Agent Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Vascular Embolization Agent Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Vascular Embolization Agent Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Vascular Embolization Agent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Vascular Embolization Agent Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Vascular Embolization Agent Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Vascular Embolization Agent Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Vascular Embolization Agent Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Vascular Embolization Agent Sales (K Units) by Type (2019-2024)
    Table 51. Global Vascular Embolization Agent Sales (K Units) by Type (2025-2030)
    Table 52. Global Vascular Embolization Agent Sales Market Share by Type (2019-2024)
    Table 53. Global Vascular Embolization Agent Sales Market Share by Type (2025-2030)
    Table 54. Global Vascular Embolization Agent Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Vascular Embolization Agent Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Vascular Embolization Agent Revenue Market Share by Type (2019-2024)
    Table 57. Global Vascular Embolization Agent Revenue Market Share by Type (2025-2030)
    Table 58. Global Vascular Embolization Agent Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Vascular Embolization Agent Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Vascular Embolization Agent Sales (K Units) by Application (2019-2024)
    Table 61. Global Vascular Embolization Agent Sales (K Units) by Application (2025-2030)
    Table 62. Global Vascular Embolization Agent Sales Market Share by Application (2019-2024)
    Table 63. Global Vascular Embolization Agent Sales Market Share by Application (2025-2030)
    Table 64. Global Vascular Embolization Agent Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Vascular Embolization Agent Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Vascular Embolization Agent Revenue Market Share by Application (2019-2024)
    Table 67. Global Vascular Embolization Agent Revenue Market Share by Application (2025-2030)
    Table 68. Global Vascular Embolization Agent Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Vascular Embolization Agent Price (US$/Unit) by Application (2025-2030)
    Table 70. Abbott Corporation Information
    Table 71. Abbott Description and Business Overview
    Table 72. Abbott Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Abbott Vascular Embolization Agent Product
    Table 74. Abbott Recent Developments/Updates
    Table 75. Boston Scientific Corporation Corporation Information
    Table 76. Boston Scientific Corporation Description and Business Overview
    Table 77. Boston Scientific Corporation Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Boston Scientific Corporation Vascular Embolization Agent Product
    Table 79. Boston Scientific Corporation Recent Developments/Updates
    Table 80. Cook Medical LLC Corporation Information
    Table 81. Cook Medical LLC Description and Business Overview
    Table 82. Cook Medical LLC Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Cook Medical LLC Vascular Embolization Agent Product
    Table 84. Cook Medical LLC Recent Developments/Updates
    Table 85. Johnson & Johnson Corporation Information
    Table 86. Johnson & Johnson Description and Business Overview
    Table 87. Johnson & Johnson Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Johnson & Johnson Vascular Embolization Agent Product
    Table 89. Johnson & Johnson Recent Developments/Updates
    Table 90. Medtronic Corporation Information
    Table 91. Medtronic Description and Business Overview
    Table 92. Medtronic Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Medtronic Vascular Embolization Agent Product
    Table 94. Medtronic Recent Developments/Updates
    Table 95. Acandis GmbH Corporation Information
    Table 96. Acandis GmbH Description and Business Overview
    Table 97. Acandis GmbH Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Acandis GmbH Vascular Embolization Agent Product
    Table 99. Acandis GmbH Recent Developments/Updates
    Table 100. SSEM Mthembu Medical (Pty) Ltd Corporation Information
    Table 101. SSEM Mthembu Medical (Pty) Ltd Description and Business Overview
    Table 102. SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Product
    Table 104. SSEM Mthembu Medical (Pty) Ltd Recent Developments/Updates
    Table 105. Balt USA LLC Corporation Information
    Table 106. Balt USA LLC Description and Business Overview
    Table 107. Balt USA LLC Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Balt USA LLC Vascular Embolization Agent Product
    Table 109. Balt USA LLC Recent Developments/Updates
    Table 110. Stryker Corporation Information
    Table 111. Stryker Description and Business Overview
    Table 112. Stryker Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Stryker Vascular Embolization Agent Product
    Table 114. Stryker Recent Developments/Updates
    Table 115. Guerbet LLC Corporation Information
    Table 116. Guerbet LLC Description and Business Overview
    Table 117. Guerbet LLC Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Guerbet LLC Vascular Embolization Agent Product
    Table 119. Guerbet LLC Recent Developments/Updates
    Table 120. Terumo Corporation Corporation Information
    Table 121. Terumo Corporation Description and Business Overview
    Table 122. Terumo Corporation Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Terumo Corporation Vascular Embolization Agent Product
    Table 124. Terumo Corporation Recent Developments/Updates
    Table 125. Penumbra Corporation Information
    Table 126. Penumbra Description and Business Overview
    Table 127. Penumbra Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Penumbra Vascular Embolization Agent Product
    Table 129. Penumbra Recent Developments/Updates
    Table 130. Grandpharma (Sirtex) Corporation Information
    Table 131. Grandpharma (Sirtex) Description and Business Overview
    Table 132. Grandpharma (Sirtex) Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Grandpharma (Sirtex) Vascular Embolization Agent Product
    Table 134. Grandpharma (Sirtex) Recent Developments/Updates
    Table 135. Merit Medical Corporation Information
    Table 136. Merit Medical Description and Business Overview
    Table 137. Merit Medical Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Merit Medical Vascular Embolization Agent Product
    Table 139. Merit Medical Recent Developments/Updates
    Table 140. Siemens Healthineers (Varian) Corporation Information
    Table 141. Siemens Healthineers (Varian) Description and Business Overview
    Table 142. Siemens Healthineers (Varian) Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Siemens Healthineers (Varian) Vascular Embolization Agent Product
    Table 144. Siemens Healthineers (Varian) Recent Developments/Updates
    Table 145. Jiangsu Hengrui Medicine Corporation Information
    Table 146. Jiangsu Hengrui Medicine Description and Business Overview
    Table 147. Jiangsu Hengrui Medicine Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. Jiangsu Hengrui Medicine Vascular Embolization Agent Product
    Table 149. Jiangsu Hengrui Medicine Recent Developments/Updates
    Table 150. Kaneka Corporation Information
    Table 151. Kaneka Description and Business Overview
    Table 152. Kaneka Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 153. Kaneka Vascular Embolization Agent Product
    Table 154. Kaneka Recent Developments/Updates
    Table 155. Meril Life Sciences Corporation Information
    Table 156. Meril Life Sciences Description and Business Overview
    Table 157. Meril Life Sciences Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 158. Meril Life Sciences Vascular Embolization Agent Product
    Table 159. Meril Life Sciences Recent Developments/Updates
    Table 160. Peijia Medical Corporation Information
    Table 161. Peijia Medical Description and Business Overview
    Table 162. Peijia Medical Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 163. Peijia Medical Vascular Embolization Agent Product
    Table 164. Peijia Medical Recent Developments/Updates
    Table 165. Wallaby Medical Corporation Information
    Table 166. Wallaby Medical Description and Business Overview
    Table 167. Wallaby Medical Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 168. Wallaby Medical Vascular Embolization Agent Product
    Table 169. Wallaby Medical Recent Developments/Updates
    Table 170. MicroPort Scientific Corporation Corporation Information
    Table 171. MicroPort Scientific Corporation Description and Business Overview
    Table 172. MicroPort Scientific Corporation Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 173. MicroPort Scientific Corporation Vascular Embolization Agent Product
    Table 174. MicroPort Scientific Corporation Recent Developments/Updates
    Table 175. Weihai Visee Medical Devices Corporation Information
    Table 176. Weihai Visee Medical Devices Description and Business Overview
    Table 177. Weihai Visee Medical Devices Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 178. Weihai Visee Medical Devices Vascular Embolization Agent Product
    Table 179. Weihai Visee Medical Devices Recent Developments/Updates
    Table 180. Beijing Taijieweiye Technology Corporation Information
    Table 181. Beijing Taijieweiye Technology Description and Business Overview
    Table 182. Beijing Taijieweiye Technology Vascular Embolization Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 183. Beijing Taijieweiye Technology Vascular Embolization Agent Product
    Table 184. Beijing Taijieweiye Technology Recent Developments/Updates
    Table 185. Key Raw Materials Lists
    Table 186. Raw Materials Key Suppliers Lists
    Table 187. Vascular Embolization Agent Distributors List
    Table 188. Vascular Embolization Agent Customers List
    Table 189. Vascular Embolization Agent Market Trends
    Table 190. Vascular Embolization Agent Market Drivers
    Table 191. Vascular Embolization Agent Market Challenges
    Table 192. Vascular Embolization Agent Market Restraints
    Table 193. Research Programs/Design for This Report
    Table 194. Key Data Information from Secondary Sources
    Table 195. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Vascular Embolization Agent
    Figure 2. Global Vascular Embolization Agent Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Vascular Embolization Agent Market Share by Type in 2023 & 2030
    Figure 4. Temporary Product Picture
    Figure 5. Permanent Product Picture
    Figure 6. Global Vascular Embolization Agent Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Vascular Embolization Agent Market Share by Application in 2023 & 2030
    Figure 8. Hospital
    Figure 9. Ambulatory Surgery Center
    Figure 10. Global Vascular Embolization Agent Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Vascular Embolization Agent Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Vascular Embolization Agent Sales (2019-2030) & (K Units)
    Figure 13. Global Vascular Embolization Agent Average Price (US$/Unit) & (2019-2030)
    Figure 14. Vascular Embolization Agent Report Years Considered
    Figure 15. Vascular Embolization Agent Sales Share by Manufacturers in 2023
    Figure 16. Global Vascular Embolization Agent Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Vascular Embolization Agent Players: Market Share by Revenue in 2023
    Figure 18. Vascular Embolization Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Vascular Embolization Agent Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Vascular Embolization Agent Sales Market Share by Country (2019-2030)
    Figure 21. North America Vascular Embolization Agent Revenue Market Share by Country (2019-2030)
    Figure 22. United States Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Vascular Embolization Agent Sales Market Share by Country (2019-2030)
    Figure 25. Europe Vascular Embolization Agent Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Vascular Embolization Agent Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Vascular Embolization Agent Revenue Market Share by Region (2019-2030)
    Figure 33. China Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Southeast Asia Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Latin America Vascular Embolization Agent Sales Market Share by Country (2019-2030)
    Figure 41. Latin America Vascular Embolization Agent Revenue Market Share by Country (2019-2030)
    Figure 42. Mexico Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Brazil Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Argentina Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Vascular Embolization Agent Sales Market Share by Country (2019-2030)
    Figure 46. Middle East & Africa Vascular Embolization Agent Revenue Market Share by Country (2019-2030)
    Figure 47. Turkey Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Saudi Arabia Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. UAE Vascular Embolization Agent Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Global Sales Market Share of Vascular Embolization Agent by Type (2019-2030)
    Figure 51. Global Revenue Market Share of Vascular Embolization Agent by Type (2019-2030)
    Figure 52. Global Vascular Embolization Agent Price (US$/Unit) by Type (2019-2030)
    Figure 53. Global Sales Market Share of Vascular Embolization Agent by Application (2019-2030)
    Figure 54. Global Revenue Market Share of Vascular Embolization Agent by Application (2019-2030)
    Figure 55. Global Vascular Embolization Agent Price (US$/Unit) by Application (2019-2030)
    Figure 56. Vascular Embolization Agent Value Chain
    Figure 57. Vascular Embolization Agent Production Process
    Figure 58. Channels of Distribution (Direct Vs Distribution)
    Figure 59. Distributors Profiles
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Therapeutic Medical Stent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8T15352
Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Vascular Embolization Agent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2D13682
Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Extravascular Implantable Cardioverter Defibrillator System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-31M15462
Thu Oct 03 00:00:00 UTC 2024

Add to Cart

Global Transcatheter Mitral Valve Clip System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38C15386
Thu Oct 03 00:00:00 UTC 2024

Add to Cart